This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Netris Pharma. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Andréa Paradisi: Innovator in Cancer Treatment
Introduction
Andréa Paradisi is a notable inventor based in Saint Quentin Fallavier, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compositions.
Latest Patents
Andréa Paradisi holds a patent for a combined treatment involving a netrin-1 interfering drug and a chemotherapeutic drug. This pharmaceutical composition comprises a chemotherapeutic drug that can induce overexpression of netrin-1 in cancer cells, combined with a netrin-1 interfering drug or a vector capable of expressing it in vivo. The combination is associated with a synergistic anti-cancer effect, showcasing the potential for improved therapeutic outcomes.
Career Highlights
Throughout his career, Paradisi has worked with various organizations, including Netris Pharma and the University Claude Bernard - Lyon 1. His work has focused on developing innovative solutions to combat cancer, emphasizing the importance of targeted therapies.
Collaborations
He has collaborated with esteemed colleagues such as Patrick Mehlen and Pascale Nony, contributing to advancements in cancer research and treatment methodologies.
Conclusion
Andréa Paradisi's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. His contributions through patents and collaborations highlight the importance of continued research in this critical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile